Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cardiometabolic traits, sepsis and severe covid-19: a Mendelian randomization investigation

Mark J Ponsford, Apostolos Gkatzionis, View ORCID ProfileVenexia M Walker, Andrew J Grant, Robyn E Wootton, Luke S P Moore, Segun Fatumo, Amy M Mason, View ORCID ProfileVerena Zuber, Cristen Willer, Humaira Rasheed, Ben Brumpton, Kristian Hveem, Jan Kristian Damås, Neil Davies, Bjørn Olav Åsvold, Erik Solligård, Simon Jones, Stephen Burgess, Tormod Rogne, View ORCID ProfileDipender Gill
doi: https://doi.org/10.1101/2020.06.18.20134676
Mark J Ponsford
1Immunodeficiency Centre or Wales, University Hospital Wales, Heath Park, Cardiff, UK
2Division of Immunology, Infection, and Inflammation, Tenovus Institute, Cardiff University, Cardiff, UK
BMBCh MSc
Roles: Welsh Clinical Academic Trainee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Apostolos Gkatzionis
3MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK
MASt PhD
Roles: Career Development Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Venexia M Walker
4MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK
5Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA
PhD
Roles: Senior Research Associate
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Venexia M Walker
Andrew J Grant
3MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK
PhD
Roles: Research Associate
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robyn E Wootton
4MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK
PhD
Roles: Postdoctoral Researcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luke S P Moore
6National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, UK
7Chelsea & Westminster NHS Foundation Trust, London, UK
8Imperial Biomedical Research Centre, Imperial College London and Imperial College NHS Healthcare Trust, London, UK
FRCPath PhD
Roles: Consultant Infectious Diseases & Clinical Microbiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Segun Fatumo
9Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, UK
PhD
Roles: Assistant Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy M Mason
10Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
11National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, UK
PhD
Roles: Research Associate
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Verena Zuber
3MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK
12Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
PhD
Roles: Lecturer in Biostatistics
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Verena Zuber
Cristen Willer
13Departments of Internal Medicine, Human Genetics and Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI, USA
PhD
Roles: Associate Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Humaira Rasheed
4MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK
14K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
PhD
Roles: Postdoctoral Researcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Brumpton
4MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK
14K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
15Department of Thoracic Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
PhD
Roles: Associate Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristian Hveem
14K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
MD PhD
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Kristian Damås
16Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
17Department of Infectious Diseases, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
MD PhD
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Davies
4MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK
14K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
PhD
Roles: Senior Research Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bjørn Olav Åsvold
14K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
MD PhD
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Solligård
18Gemini Center for Sepsis Research, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
MD PhD
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Jones
2Division of Immunology, Infection, and Inflammation, Tenovus Institute, Cardiff University, Cardiff, UK
PhD
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Burgess
3MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK
10Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
PhD
Roles: Statistician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tormod Rogne
18Gemini Center for Sepsis Research, Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
MD PhD
Roles: Postdoctoral Researcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dipender Gill
19Department of Epidemiology and Biostatistics, Medical School Building, St Mary’s Hospital, Imperial College London, London, UK
BMBCh PhD
Roles: Clinician Scientist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dipender Gill
  • For correspondence: dipender.gill{at}imperial.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To investigate whether there is a causal effect of cardiometabolic traits on risk of sepsis and severe covid-19.

Design Mendelian randomisation analysis.

Setting UK Biobank and HUNT study population-based cohorts for risk of sepsis, and genome-wide association study summary data for risk of severe covid-19 with respiratory failure.

Participants 12,455 sepsis cases (519,885 controls) and 1,610 severe covid-19 with respiratory failure cases (2,205 controls).

Exposure Genetic variants that proxy body mass index (BMI), lipid traits, systolic blood pressure, lifetime smoking score, and type 2 diabetes liability - derived from studies considering between 188,577 to 898,130 participants.

Main outcome measures Risk of sepsis and severe covid-19 with respiratory failure.

Results Higher genetically proxied BMI and lifetime smoking score were associated with increased risk of sepsis in both UK Biobank (BMI: odds ratio 1.38 per standard deviation increase, 95% confidence interval [CI] 1.27 to 1.51; smoking: odds ratio 2.81 per standard deviation increase, 95% CI 2.09-3.79) and HUNT (BMI: 1.41, 95% CI 1.18 to 1.69; smoking: 1.93, 95% CI 1.02-3.64). Higher genetically proxied BMI and lifetime smoking score were also associated with increased risk of severe covid-19, although with wider confidence intervals (BMI: 1.75, 95% CI 1.20 to 2.57; smoking: 3.94, 95% CI 1.13 to 13.75). There was limited evidence to support associations of genetically proxied lipid traits, systolic blood pressure or type 2 diabetes liability with risk of sepsis or severe covid-19. Similar findings were generally obtained when using Mendelian randomization methods that are more robust to the inclusion of pleiotropic variants, although the precision of estimates was reduced.

Conclusions Our findings support a causal effect of elevated BMI and smoking on risk of sepsis and severe covid-19. Clinical and public health interventions targeting obesity and smoking are likely to reduce sepsis and covid-19 related morbidity, along with the plethora of other health-related outcomes that these traits adversely affect.

What is already known on this topic

  • Sepsis and severe covid-19 are major contributors to global morbidity and mortality.

  • Cardiometabolic risk factors have been associated with risk of sepsis and severe covid-19, but it is unclear if they are having causal effects.

What this study adds

  • Using Mendelian randomization analyses, this study provides evidence to support that higher body mass index and lifetime smoking score both increase risk of sepsis and severe covid-19 with respiratory failure.

  • Clinical and public health interventions targeting obesity and smoking are likely to reduce sepsis and covid-19 related morbidity, along with the plethora of other health-related outcomes that these traits adversely affect.

Competing Interest Statement

LSPM has consulted for DNAelectronics (2015-18), Dairy Crest (2017-2018), bioMerieux (2013-20), Pfizer (2018-2020), and Umovis Lab (2020), received speaker fees from Profile Pharma (2018), received research grants from the National Institute for Health Research (2013-2020), CW+ Charity (2018-2019), and Leo Pharma (2016), and received educational grants from Eumedica (2016-2018). DG is employed part-time by Novo Nordisk. All other authors have no conflicts of interest to declare.

Funding Statement

MJP is a funded by the Welsh Clinical Academic Training (WCAT) programme and is a participant in the NIH Graduate Partnership Program. AG1 is funded by a Medical Research Council Methodology Research Panel grant (RG88311). VW is supported by the Medical Research Council (MRC) Integrative Epidemiology Unit. The MRC and the University of Bristol support the MRC Integrative Epidemiology Unit [MC_UU_12013/1, MC_UU_12013/9, MC_UU_00011/1]. REW is supported by Wellcome Trust grant (204895/Z/16/Z). LSPM acknowledges the National Institute of Health Research (NIHR) Imperial Biomedical Research Centre (BRC) and the NIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London in partnership with Public Health England. NMD is supported by a Norwegian Research Council Grant number 295989. SB and AG2 are supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (204623/Z/16/Z). DG is supported by the Wellcome 4i Program (203928/Z/16/Z) and British Heart Foundation Research Centre of Excellence (RE/18/4/34215) at Imperial College London. The funding sources did not have any role in designing the study, performing analysis or communicating findings.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The data used in this work obtained relevant participant consent and ethical approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Competing interest statement All authors have completed the Unified Competing Interest form (available on request from the corresponding author) and declare: LSPM has consulted for DNAelectronics (2015-18), Dairy Crest (2017–2018), bioMerieux (2013-20), Pfizer (2018-2020), and Umovis Lab (2020), received speaker fees from Profile Pharma (2018), received research grants from the National Institute for Health Research (2013-2020), CW+ Charity (2018-2019), and Leo Pharma (2016), and received educational grants from Eumedica (2016–2018). DG is employed part-time by Novo Nordisk. All other authors have no conflicts of interest to declare.

  • Transparency declaration The corresponding authors affirm that the manuscript is an honest, accurate, and transparent account of the research being reported, and that no important aspects of the study have been omitted.

  • Dissemination declaration This work uses genetic association summary data and dissemination to the participants that contributed these data is therefore not possible.

  • Copyright The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non-exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in BMJ editions and any other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our licence.

  • Funding MJP is a funded by the Welsh Clinical Academic Training (WCAT) programme and is a participant in the NIH Graduate Partnership Program. AG1 is funded by a Medical Research Council Methodology Research Panel grant (RG88311). VW is supported by the Medical Research Council (MRC) Integrative Epidemiology Unit. The MRC and the University of Bristol support the MRC Integrative Epidemiology Unit [MC_UU_12013/1, MC_UU_12013/9, MC_UU_00011/1]. REW is supported by Wellcome Trust grant (204895/Z/16/Z). LSPM acknowledges the National Institute of Health Research (NIHR) Imperial Biomedical Research Centre (BRC) and the NIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London in partnership with Public Health England. NMD is supported by a Norwegian Research Council Grant number 295989. SB and AG2 are supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (204623/Z/16/Z). DG is supported by the Wellcome 4i Program (203928/Z/16/Z) and British Heart Foundation Research Centre of Excellence (RE/18/4/34215) at Imperial College London. The funding sources did not have any role in designing the study, performing analysis or communicating findings.

Data Availability

All variants used as instruments and their genetic association estimates were selected from publicly available data sources, and are provided in Supplementary Tables 2-6. The results from the analyses performed in this work are presented in the main manuscript or its supplementary files. This paper has been reported based on recommendations by the STROBE-MR Guidelines (Supplementary Research Checklist).41 The study protocol and details were not pre-registered. Code for analyses are available via the online Github repository (https://github.com/agkatzionis/Sepsis-MR).

https://github.com/agkatzionis/Sepsis-MR

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted June 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cardiometabolic traits, sepsis and severe covid-19: a Mendelian randomization investigation
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cardiometabolic traits, sepsis and severe covid-19: a Mendelian randomization investigation
Mark J Ponsford, Apostolos Gkatzionis, Venexia M Walker, Andrew J Grant, Robyn E Wootton, Luke S P Moore, Segun Fatumo, Amy M Mason, Verena Zuber, Cristen Willer, Humaira Rasheed, Ben Brumpton, Kristian Hveem, Jan Kristian Damås, Neil Davies, Bjørn Olav Åsvold, Erik Solligård, Simon Jones, Stephen Burgess, Tormod Rogne, Dipender Gill
medRxiv 2020.06.18.20134676; doi: https://doi.org/10.1101/2020.06.18.20134676
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Cardiometabolic traits, sepsis and severe covid-19: a Mendelian randomization investigation
Mark J Ponsford, Apostolos Gkatzionis, Venexia M Walker, Andrew J Grant, Robyn E Wootton, Luke S P Moore, Segun Fatumo, Amy M Mason, Verena Zuber, Cristen Willer, Humaira Rasheed, Ben Brumpton, Kristian Hveem, Jan Kristian Damås, Neil Davies, Bjørn Olav Åsvold, Erik Solligård, Simon Jones, Stephen Burgess, Tormod Rogne, Dipender Gill
medRxiv 2020.06.18.20134676; doi: https://doi.org/10.1101/2020.06.18.20134676

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3294)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13376)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3269)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14629)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)